Ronald Xavier Collins v. United States of America

• Court: District Court, C.D. California
• Decided: November 22, 2023
• Docket: 5:20-cv-02582
• Status: Unknown

Opinion

1 O 2

9 UNITED STATES DISTRICT COURT 10 CENTRAL DISTRICT OF CALIFORNIA 11

12 Case No.: 5:20-cv-02582-MEMF (SHKx) RONALD XAVIER COLLINS,

13 Plaintiff, ORDER GRANTING IN PART 14 DEFENDANTS’ MOTION IN LIMINE NO. 1 v. [ECF NO. 56] 15

16 THE UNITED STATES OF AMERICA;

UNITED STATES DEPARTMENT OF 17 JUSTICE – BUREAU OF PRISONS; 18 MICHAEL CARVAJAL: WILLIAM WATSON, M.D.; AND, DOES 1 TO 10, 19 INCLUSIVE, 20 Defendants.

21 22 23 Before the Court is a Motion in Limine filed by Defendant United States of America. ECF 24 No. 56. For the reasons stated herein, the Court GRANTS IN PART the Motion in Limine. 25 26 / / / 27 / / / 28 / / / 1 I. Background 2 A. Factual Background1 3 Plaintiff Ronald Xavier Collins (“Collins”) is a former prison inmate at the United States 4 Penitentiary in Lompoc, California. FAC ¶ 1. While in federal custody, he underwent a colonoscopy 5 to screen for a malignant neoplasm. Id. ¶ 13. Following the colonoscopy, Collins complained of pain 6 in his lower abdominal wall. Id. He also complained of pain from consistently passing gas through 7 his penile urethra. Id. at 15. While under the care of Defendant, William Watson, M.D. (“Dr. 8 Watson”), Collins was diagnosed with an enterovesical fistula. Id. While incarcerated, including 9 after the diagnosis, Collins was required to wear ankle shackles, which caused injuries to his ankles. 10 Id. at 16. Following the diagnosis, Collins received no further care from prison medical staff. Id. at 11 15. 12 B. Procedural History 13 Collins suit in this Court on December 15, 2020. ECF No. 1. On October 25, 2021, Collins 14 filed his First Amended Complaint. ECF No. 31 (“FAC”). Collins brings one cause of action: 15 medical negligence action under the Federal Torn Claims Act (“FTCA”) for the improper placement 16 of shackles which exacerbated the pain from his condition and caused “ankle ulcers”. See id. Collins 17 brings this claim against Defendants United States of America, United States Department of Justice 18 Bureau of Prisons, Michael Carvajal, and Dr. Watson (collectively, “Defendants”). See id. 19 Defendants answered on November 15, 2021. ECF No. 32. 20 On August 30, 2023, Defendants filed this Motion in Limine. ECF No. 56 (“Motion” or 21 “Mot.”). On September 11, 2023, Collins filed an Opposition to the Motion. ECF No. 57 22 (“Opposition” or “Opp’n”). On September 19, 2023, Defendants filed a reply in support of the 23 Motion in Limine. ECF No. 59 (“Reply”). 24 The Court held a hearing on the Motion on October 18, 2023. 25 26

27 1 The following factual background is derived from the allegations in Plaintiff Ronald Xavier Collins’s First Amended Complaint, ECF No. 31 (“FAC”), except where otherwise indicated. The Court makes no finding 28 1 II. Applicable Law 2 A. Motions in Limine 3 A motion in limine is “a procedural mechanism to limit in advance testimony of evidence in a 4 particular area.” United States v. Heller, 551 F.3d 1108, 1111 (9th Cir. 2009). A party files a motion 5 in limine to exclude anticipated prejudicial evidence before the evidence is introduced at trial. See 6 Luce v. United States, 469 U.S. 38, 40 n.2 (1984). A court has the power to grant such motions 7 pursuant to its “inherent authority to manage trials,” even though such rulings are not explicitly 8 authorized by the Federal Rules of Evidence. Id. at 41 n.4 (citation omitted). Regardless of a court’s 9 initial decision on a motion in limine, it may revisit the issue at trial. Id. at 41—42 (“[E]ven if 10 nothing expected happens at trial, the district judge is free, in the exercise of sound judicial 11 discretion, to alter a previous in limine ruling.”). 12 B. Daubert v. Merrell Dow Pharms., Inc. 13 Trial courts have a “gatekeeping role” in “ensuring that an expert's testimony both rests on a 14 reliable foundation and is relevant to the task at hand.” Daubert v. Merrell Dow Pharms., Inc., 509 15 U.S. 579, 597 (1993). Qualification of an expert witness must be established by a preponderance of 16 the evidence. See id. at 592 n.10. As a result, before admitting expert testimony, courts must make a 17 “preliminary assessment” of: (1) whether the expert is qualified to present the opinion offered; (2) 18 “whether the reasoning or methodology underlying the testimony is scientifically valid” (i.e., 19 reliable); and (3) “whether that reasoning or methodology can properly be applied to the facts in 20 issue” (i.e., relevant). Id. at 592–93. “Expert opinion testimony is relevant if the knowledge 21 underlying it has a valid connection to the pertinent inquiry. And it is reliable if the knowledge 22 underlying it has a reliable basis in the knowledge and experience of the relevant discipline.” Alaska 23 Rent-A-Car, Inc. v. Avis Budget Grp., Inc., 738 F. 3d 960, 969 (9th Cir. 2013). 24 When the reliability or relevance of a proffered expert’s testimony is challenged, the party 25 that preferred the expert bears the burden of showing that the expert’s testimony meets the Daubert 26 standard. United States v. Valencia-Lopez, 971 F.3d 891, 900 (9th Cir. 2020). 27 / / / 28 1 C. Federal Rule of Civil Procedure 26 2 Under Federal Rule of Civil Procedure 26(a)(2), a party is required to disclose an expert 3 witness and submit an accompanying report prepared and signed by the witness. Fed. R. Civ. P. 4 26(a)(2)(A)–(B) (emphasis added). This written report must contain, in part: (1) a complete 5 statement of all opinions expressed by the witness and the “basis and reasons for them”; (2) the facts 6 and data used by the witness in forming his or her opinions; and (3) the exhibits that will be used to 7 support or summarize the opinions. Fed. R. Civ. P. 26(a)(2)(B)(i)–(iii). 8 D. Federal Rule of Civil Procedure 37 9 Rule 37(c)(1) gives teeth to the requirements above requirements by forbidding the use at 10 trial of any information required to be disclosed by Rule 26(a) that is not properly disclosed. Yeti by 11 Molly, Ltd. v. Deckers Outdoor Corp., 259 F.3d 1101, 1106 (9th Cir. 2001). Federal Rule of Civil 12 Procedure 37(c) is “an ‘automatic’ sanction that prohibits the use of improperly disclosed evidence 13 should a party fail to provide information or identify a witness as required by Rule 26(a) or (e). 14 Merchant v. Corizon Health, Inc., 993 F.3d 733, 740 (9th Cir. 2021) (citing Yeti by Molly, Ltd. v. 15 Deckers Outdoor Corp., 259 F.3d 1101, 1106 (9th Cir. 2001)). The Rule states that, “If a party fails 16 to provide information or identify a witness as required by Rule 26(a) or (e), the party is not allowed 17 to use that information or witness to supply evidence on a motion, at a hearing, or at a trial, unless 18 the failure was substantially justified or is harmless.” Fed. R. Civ. P. 37(c)(1). Implicit in Rule 19 37(c)(1), “is that the burden is on the party facing sanctions to prove harmlessness.” Yeti, 259 F.3d 20 1101, 1107 (9th Cir. 2001). Further, “in addition to or instead of this sanction, the court, on motion 21 and after giving an opportunity to be heard” may order payments of expenses caused by the failure, 22 inform the jury of the failure, and impose other appropriate sanctions. Fed. R. Civ. P. 37(c)(1). 23 III. Discussion 24 Defendants move to exclude at trial all planned testimony from Collins’ proffered expert, Dr. 25 Stein, on two bases: (1) that Dr. Stein signed off on a “ghostwritten” report, and alternatively, (2) 26 because Dr. Stein is unqualified to offer relevant expert opinions in this case. See Mot. 27 The Court finds that Dr. Stein did not participate in the preparation of the report as required 28 by Rule 26. However, the Court finds that this violation of Rule 26 was harmless, and therefore the 1 Court will not exclude Dr. Stein’s testimony under Rule 37. The Court will limit his testimony to the 2 opinions disclosed in deposition, and to subjects on which he is qualified to testify, as described in 3 more detail below. 4 A. Dr. Stein did not participate in writing the report as required by Rule 26. 5 Rule 26 requires that a party intending to proffer an expert witness must disclose a report 6 “prepared and signed by the witness.” Fed. R. Civ. P. 26(a)(2)(B). “Rule 26(a)(2)(B) does not 7 preclude counsel from providing assistance to experts in preparing the reports,” or prohibit counsel 8 from preparing drafts based on communications with an expert, but does prohibit an attorney from 9 “simply draft[ing] the report without prior substantive input from [the expert] expert” and presenting 10 the report to the expert for a signature. Fed. R. Civ. P. 26, Advisory Committee’s Note to 1993 11 Amendment. Here, the Court finds that the report was not prepared by Dr. Stein. 12 Dr. Stein was deposed twice. In his first deposition, on May 23, 2023, Dr. Stein explained the 13 process through which he signed the expert report. See ECF No. 56-3. Dr. Stein’s explanation in the 14 first deposition was as follows: Graham (Collins’s counsel) retained Dr. Stein on May 9, 2023. ECF 15 No. 56-3 at 11 (Stein Tr. I 63:10–13). Prior to May 9, 2023, Dr. Stein did not know anything about 16 the case, ECF No. 56-3 at 11 (Stein Tr. I 63:17–19), although he had spoken to Graham on the 17 phone, ECF No. 56-3 at 11 (Stein Tr. I 70:22–71:9). Graham came to meet Dr. Stein at his home on 18 May 9, 2023, and the two met for less than an hour. ECF No. 56-3 at 11–12 (Stein Tr. I 63:17–19, 19 64:02–0)6. In that meeting, Graham presented Dr. Stein with certain records related to the case and a 20 fully written expert report. ECF No. 56-3 at 12–13 (Stein Tr. I 64:07–14, 65:11–20). Dr. Stein 21 reviewed the draft expert report prepared by Graham and signed the report. ECF No. 56-3 at 5 (Stein 22 Tr. I 27:02–04). As the expert report makes clear, Dr. Stein signed it on May 9, 2023. See ECF No. 23 56-2. 24 In his second deposition, Dr. Stein presented a slightly different story. See ECF No. 56-4; 25 ECF No. 57-1. Dr. Stein’s relevant testimony in the second deposition is as follows: Approximately 26 ten days before the May 9 meeting, Graham and Dr. Stein spoke on the phone. ECF No. 56-4 at 5 27 (Stein Tr. II 178:05–13). This phone conversation lasted approximately an hour and a half. ECF No. 28 56-4 at 4 (Stein Tr. II 177:22–25). Dr. Stein had no medical records in front of him during that phone 1 call. ECF No. 56-4 at 5 (Stein Tr. II 178:01–05). When Graham came to Dr. Stein’s house on May 9, 2 the two went over the medical records and went over the expert report “page by page, line by line.” 3 ECF No. 57-1 at 3–4 (Stein Tr. II 236:21–237:03). Although Graham wrote the report, the opinions 4 in the report were Dr. Stein’s opinions at the time he signed it. ECF No. 57-1 at 4 (Stein Tr. II 5 237:12–16). Dr. Stein signed the report in Graham’s presence during the May 9 meeting. ECF No. 6 56-4 at 5 (Stein Tr. II 178:21–24). 7 Based on the testimony above, the Court concludes that Dr. Stein did not “prepare” the report 8 as required by Federal Rule of Civil Procedure 26, and instead merely signed it. Dr. Stein’s claim in 9 his second deposition that he had a long phone call with Mr. Graham ten days prior to the May 9 10 meeting is not credible.2 Dr. Stein previously testified that he was retained on May 9, and that prior 11 to that date, he had no knowledge of the case. See ECF No. 56-3 at 11 (Stein Tr. I 63:10–13); ECF 12 No. 56-3 at 11 (Stein Tr. I 63:17–19). The testimony in the two depositions is nearly impossible to 13 reconcile, and the Court finds it far more likely that Dr. Stein’s testimony in the first deposition 14 represented the actual facts of what occurred than that Dr. Stein’s attempt to rehabilitate himself in 15 the second deposition does. Furthermore, even if the phone call took place, it still would not be clear 16 that the report represented Dr. Stein’s opinions or that he assisted in preparing it. Even accepting the 17 version of events in Dr. Stein’s second deposition as correct, Dr. Stein had no medical records in 18 front of him during the phone call. See ECF No. 56-4 at 5 (Stein Tr. II 178:01–05). Then, in a 19 meeting that lasted less than an hour, Dr. Stein reviewed all relevant medical records and reviewed 20 the report “line by line,” and concluded that the first draft Graham prepared fully perfectly captured 21 Dr. Stein’s view of the case. See ECF No. 57-1 at 3–4 (Stein Tr. II 236:21–237:03). The Court does 22 not find it credible that the report expressed opinions that were Dr. Stein’s at the time Dr. Stein 23 signed the report. The facts above show that Graham did not prepare the report with Dr. Stein’s 24 assistance as the rule contemplates. Rather, Graham prepared the report and presented it to Dr. Stein 25 26

27 2 The Court’s finding that Dr. Stein’s testimony is not credible is limited to Dr. Stein’s testimony as to the preparation of the report. The Court is not finding, at least at this stage, that Dr. Stein’s testimony as whole is 28 1 for a signature, which is not permitted. See Fed. R. Civ. P. 26, Advisory Committee’s Note to 1993 2 Amendment. 3 Precedent does not make clear which party bears the burden of showing whether Dr. Stein 4 prepared the report. If it is shown that Dr. Stein did not prepare the report, then the burden would be 5 on Collins to show that Dr. Stein’s violation of Rule 26 was harmless. See Yeti by Molly, 259 F.3d at 6 1107. The Court need not settle which party bears the initial burden of showing a violation of Rule 7 26. Even assuming that Defendants bear the burden, Defendants have met that assumed burden 8 based on the facts above, and have shown by preponderance of the evidence that Dr. Stein did not 9 prepare his expert report, and thus have shown a violation of Rule 26. 10 Accordingly, under Rule 37, the Court may sanction Collins for the violation of Rule 26 by 11 excluding Dr. Stein’s testimony, unless Collins shows that the violation of Rule 26 was harmless. 12 B. The violation of Rule 26 was harmless. 13 When a party fails to disclose an expert report written by the expert as required by Rule 26, 14 the expert may be precluded from testifying unless the violation was “substantially justified or 15 harmless.” Yeti by Molly, 259 F.3d at 1107. The “burden is on the party facing sanctions to prove 16 harmlessness.” Here, Collins met his burden. 17 At the hearing, Defendants presented two arguments as to why there was harm: (1) that 18 Defendants were forced to expend resources to take a second deposition of Dr. Stein because of the 19 violation; and (2) that if Dr. Stein presents opinions that are not truly his own, there is inherent harm. 20 First, the Court is not convinced that, assuming that the violation of Rule 26 forced 21 Defendants to take a second deposition, this would be harm sufficient to exclude Dr. Stein. To the 22 extent that this might constitute harm, the harm has already occurred and been sufficiently remedied 23 as the Defendants were able to take the second deposition. Allowing Dr. Stein to testify will not 24 cause any prejudice Defendants or cause any further expenditure of resources. 25 Second, the Court is not convinced that Dr. Stein intends to testify as to any opinions he does 26 not truly hold. Dr. Stein testified in deposition that he adopted all opinions in the report, and “totally 27 agreed” with them. See ECF No. 56-4 at 5 (Stein Tr. II at 178:14–20). Other than the fact that Dr. 28 Stein did not write the initial report, nothing suggests that Dr. Stein does not truly hold the opinions 1 expressed in the report. Dr. Stein also made clear in deposition that he has additional opinions, and 2 nothing suggests that Dr. Stein does not hold those additional opinions which the initial report 3 omitted. See ECF No. 56-3 at 15 (Stein Tr. I 71:10–16). Defendants may cross examine Dr. Stein at 4 trial on how he came to his opinions and may use the story of how the report was crafted to show 5 bias if they so desire. But, having reviewed the evidence, the Court does not find that Dr. Stein 6 intends to testify as to opinions he does not truly hold. 7 Third, the Court notes that Defendants are now and have long been on notice as to what 8 opinions Dr. Stein will testify to. If Dr. Stein were to surprise Defendants at trial with new opinions, 9 this might constitute harm. But Dr. Stein has extensively explained the opinions he intends to testify 10 to in two depositions, and Defendants had an opportunity to prepare for the second deposition and 11 ask Dr. Stein questions on opinions that were not disclosed in the initial report. The Court will limit 12 Dr. Stein’s testimony to opinions expressed in his depositions or in the report, and Defendants may 13 object to any opinions that were not disclosed should Dr. Stein offer any such opinions at trial. 14 Because Defendants are on notice as to what Dr. Stein will testify as to, the Court finds that the 15 violation of Rule 26 was harmless.

16 C. Dr. Stein may not testify as to the standard of care for general practitioners, ankle ulcers, or duress and/or coercion. 17 18 Dr. Stein’s expertise is as a urologist, a specialty Dr. Stein has practiced in for 45 years. See 19 ECF No. 56-2 at 3–4. A urologist is “a physician who specializes in the urinary or urogenital tract.”3 20 Dr. Stein does not appear to have any expertise beyond urology. 21 Before allowing testimony on any subject, the Court is obligated to make a preliminary 22 assessment of whether the expert is qualified to present the opinion offered. See Daubert, 509 U.S. at 23 592–93. The Court finds that Dr. Stein is not qualified to testify on any subjects other than urology. 24 Defendants moved to exclude three categories of Dr. Stein’s testimony based on Daubert: (1) 25 opinions on the standard of care for general practitioners (distinct from the standard of care for 26 27 3 See Uroglist, Merriam-Webster’s Online Dictionary, https://www.merriam-webster.com/dictionary/urologist 28 I | specialists in urology), (2) opinions on ankle ulcers, and (3) opinions on whether Collins’ refusal to 2 || be treating was acquired under duress and coercion. See Mot. at 7. The Court finds that all three of 3 || these subjects are beyond Dr. Stein’s expertise. Therefore, Dr. Stein may not testify on these three 4 | subjects. 5 Dr. Stein may testify on Collins’s condition (to the extent that condition relates to Collins’ 6 || urinary tract, i.e., not aspects of Collins’s condition related to ankle ulcers or other non-urinary 7 | issues) and may testify on what caused or exacerbated that condition. 8 IV. Conclusion 9 For the reasons stated herein, the Court GRANTS IN PART Defendants’ Motion. Dr. Stein 10 | may testify at trial only on Collins’s urinary-tract-related condition and the causes of this condition, 11 | but may not testify on the standard of care for a general practitioner, on aspects of Collins’s 12 | condition related to ankle ulcers, or on whether duress or coercion were used to acquire Collins’s 13 | refusal to be treated. Further, Dr. Stein may not offer any opinions that were not disclosed in either 14 | his depositions or in his adopted expert report. 15 16 17 IT IS SO ORDERED. 18 f= 19 Dated: November 22, 2023 20 MAAME EWUSI-MENSAH FRIMPONG 21 United States District Judge 22 23 24 25 26 27 28